Works matching IS 01609289 AND DT 2017 AND VI 40 AND IP 2


Results: 11
    1
    2

    Issue Information.

    Published in:
    Clinical Cardiology, 2017, v. 40, n. 2, p. 55, doi. 10.1002/clc.22617
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the FOURIER trial

    Published in:
    Clinical Cardiology, 2017, v. 40, n. 2, p. 59, doi. 10.1002/clc.22678
    By:
    • Giugliano, Robert P.;
    • Mach, Francois;
    • Zavitz, Kenton;
    • Kurtz, Christopher;
    • Schneider, Jingjing;
    • Wang, Huei;
    • Keech, Anthony;
    • Pedersen, Terje R.;
    • Sabatine, Marc S.;
    • Sever, Peter S.;
    • Honarpour, Narimon;
    • Wasserman, Scott M.;
    • Ott, Brian R.
    Publication type:
    Article